S3
Section 32
Venture CapitalActiveSection 32 is a venture capital fund founded by Bill Maris.
44
Investments
4
Exits
$481M
AUM
9.1%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Section 32.
Investment Thesis & Strategy
Section 32 invests in various stages of fintech and venture capital companies, seeking to back innovative and transformative businesses.
Investment Activity
Deals per year over the last 6 years
3
20151
20164
20171
20182
20191
2020Portfolio Companies
Selected investments from their portfolio of 44 companies
C
Cerebral
Healthcare · Series A, 2020
I
Insitro
Biotech · Series B, 2019
A
Alto Pharmacy
Healthcare · Series C+, 2019
L
Lyra Health
Healthcare · Series C+, 2018
P
PathAI
AI/ML · Series B, 2017
R
Recursion Pharmaceuticals
Biotech · Series B, 2017
V
Vir Biotechnology
Biotech · Series A, 2017
T
Tempus
Healthcare · Series B, 2017
C
Carbon Health
Healthcare · Series B, 2016
L
Livongo
Healthcare · Series C+, 2015
O
Outreach
SaaS · Series B, 2015
A
Aledade
Healthcare · Series B, 2015
Frequently Asked Questions
Section 32 focuses on Series A, Series B, Series C+ stage investments.
Related Investors
Correlation Ventures
San Diego, United States · 264 deals
Domain Associates
San Diego, United States · 254 deals
Mission Ventures
San Diego, United States · 101 deals
Hinge Capital
San Diego, United States · 64 deals
Finistere Ventures
San Diego, United States · 35 deals
Windward Ventures
San Diego, United States · 34 deals